Oryzon Genomics SA (ORYZF)
3.36
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Oryzon Genomics Price : 3.36 for Aug. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 3.36 | 3.36 | 3.36 | 3.36 | 0.000 |
| Aug 20, 2026 | 3.36 | 3.36 | 3.36 | 3.36 | 0.000 |
| Aug 19, 2026 | 3.36 | 3.36 | 3.36 | 3.36 | 0.000 |
| Aug 18, 2026 | 3.36 | 3.36 | 3.36 | 3.36 | 0.000 |
| Aug 17, 2026 | 3.36 | 3.36 | 3.36 | 3.36 | 0.000 |
| Aug 14, 2026 | 3.30 | 3.36 | 3.30 | 3.36 | 11500.00 |
| Aug 13, 2026 | 3.37 | 3.37 | 3.37 | 3.37 | 0.000 |
| Aug 12, 2026 | 3.37 | 3.37 | 3.37 | 3.37 | 0.000 |
| Aug 11, 2026 | 3.36 | 3.37 | 3.36 | 3.37 | 10000.00 |
| Aug 10, 2026 | 3.50 | 3.50 | 3.50 | 3.50 | 0.000 |
| Aug 07, 2026 | 3.50 | 3.50 | 3.50 | 3.50 | 0.000 |
| Aug 06, 2026 | 3.50 | 3.50 | 3.50 | 3.50 | 0.000 |
| Aug 05, 2026 | 3.50 | 3.50 | 3.50 | 3.50 | 0.000 |
| Aug 04, 2026 | 3.50 | 3.50 | 3.50 | 3.50 | 0.000 |
| Aug 03, 2026 | 3.50 | 3.50 | 3.50 | 3.50 | 0.000 |
| Jul 31, 2026 | 3.50 | 3.50 | 3.50 | 3.50 | 500.00 |
| Jul 30, 2026 | 3.45 | 3.45 | 3.45 | 3.45 | 0.000 |
| Jul 29, 2026 | 3.45 | 3.45 | 3.45 | 3.45 | 0.000 |
| Jul 28, 2026 | 3.45 | 3.45 | 3.45 | 3.45 | 0.000 |
| Jul 27, 2026 | 3.45 | 3.45 | 3.45 | 3.45 | 100.00 |
| Jul 24, 2026 | 3.655 | 3.655 | 3.655 | 3.655 | 0.000 |
| Jul 23, 2026 | 3.655 | 3.655 | 3.655 | 3.655 | 0.000 |
| Jul 22, 2026 | 3.655 | 3.655 | 3.655 | 3.655 | 0.000 |
| Jul 21, 2026 | 3.655 | 3.655 | 3.655 | 3.655 | 0.000 |
| Jul 20, 2026 | 3.655 | 3.655 | 3.655 | 3.655 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pharma Mar SA | 87.58 |
| Grifols SA | 7.985 |
| ACADIA Pharmaceuticals, Inc. | 29.63 |
| Alkermes Plc | 48.85 |
| Alnylam Pharmaceuticals, Inc. | 236.06 |
Price Related Metrics
| Price to Book Value | 2.186 |
| Earnings Yield | -1.06% |
| Market Cap | 260.46M |